Status:
UNKNOWN
Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Androgenetic Alopecia
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
Laser sources have established their potential effect in inducing hair regrowth. No study has compared the effect of ablative fractional 2940-nm erbium yttrium aluminum garnet (Er: YAG) laser and non-...
Detailed Description
The investigators performed a prospective study between to compare the efficacy and safety of ablative fractional 2940-nm erbium yttrium aluminum garnet (Er: YAG) laser and non-fractional 15650nm frac...
Eligibility Criteria
Inclusion
- age between 18 and 65 years;；
- clinical diagnosis of AGA；
- AGA diagnosis was evaluated following Norwood Hamilton grade II-V criteria；
- no previous laser treatments for AGA in the past six months before enrollment；
- willingness to provide pictures and follow-up studies.
Exclusion
- if presented with severe diseases of internal organs, eyes, or skin;
- inflammation, infection, or unhealed wounds on the skin around the site of treatment on the head;
- systematic treatment with corticosteroids or other immunosuppressants and immunomodulators in the past 3 months
Key Trial Info
Start Date :
November 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT06218498
Start Date
November 24 2023
End Date
December 31 2024
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, China, 310009